Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07046494
PHASE2

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder

Sponsor: Rapport Therapeutics Inc.

View on ClinicalTrials.gov

Summary

This is a clinical research study for an investigational drug called RAP-219 in participants with bipolar I disorder. This study is being conducted to determine if RAP-219 is safe and effective in participants experiencing mania associated with bipolar I disorder.

Official title: A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

224

Start Date

2025-07-25

Completion Date

2026-12

Last Updated

2026-04-02

Healthy Volunteers

No

Interventions

DRUG

RAP-219

RAP-219 tablets administered orally, once daily for 21 days

OTHER

Placebo

Matching placebo tablets administered orally, once daily for 21 days

Locations (22)

Pillar Clinical Research - Little Rock

Little Rock, Arkansas, United States

Woodland International Research Group

Little Rock, Arkansas, United States

Woodland Research Northwest

Rogers, Arkansas, United States

Inland Psychiatric Medical Group - Chino

Chino, California, United States

Synergy Clinical Research Center - San Diego

Lemon Grove, California, United States

Collaborative Neuroscience Research - Los Alamitos

Los Alamitos, California, United States

NRC Research Institute - Orange

Orange, California, United States

CNRI - San Diego, LLC

San Diego, California, United States

NeuroBehavioral Hospitals of the Palm Beaches - South

Boynton Beach, Florida, United States

United Research Institute

Hialeah, Florida, United States

CenExel - Hollywood

Hollywood, Florida, United States

Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site

Miami Lakes, Florida, United States

Neuroscience Research Institute at Ambrosia

West Palm Beach, Florida, United States

CenExel - Decatur

Decatur, Georgia, United States

Pillar Clinical Research - Chicago

Chicago, Illinois, United States

CenExel - Gaithersburg

Gaithersburg, Maryland, United States

Arch Clinical Trials

St Louis, Missouri, United States

Richmond Behavioral Associates

Staten Island, New York, United States

New Hope Clinical Research

Charlotte, North Carolina, United States

Community Clinical Research, Inc.

Austin, Texas, United States

HD Research - Memorial Hermann Village

Houston, Texas, United States

Pillar Clinical Research - Richardson

Richardson, Texas, United States